The Argument for a Second Independent Organization Dedicated Solely to Investigating Drug Safety

A recent article by Joe Graedon compares the FDA and the way the US investigates drug safety to the Federal Aviation Administration (FAA) and the National Transportation Safety Board (NTSB).…

Continue Reading The Argument for a Second Independent Organization Dedicated Solely to Investigating Drug Safety

New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Acute Myelogenous Leukemia Acute myelogenous leukemia (AML) is a rare blood cancer whose prevalence increases with age. There are still extremely limited treatment options for AML and the five-year survival…

Continue Reading New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Yet Another Study Shows the Dire Need for More Diversity in Medical Research

A recent study published in Cell has exhibited the scientific community's negligence for conducting research that includes an adequate representation of non-Europeans. Specifically, it showed that 78% of patients in genomic…

Continue Reading Yet Another Study Shows the Dire Need for More Diversity in Medical Research

Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial

According to a story from BioSpace, the biotechnology company Spruce Biosciences recently announced that they have achieved positive proof of concept data in the company's clinical trial. This is a…

Continue Reading Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial

GAPVAC Project Tests An Individualized Form of  Immunotherapy to Treat Aggressive Brain Cancer

A recent article in the journal Nature reports that Phase 1 GAPVAC-101 First-In-Human trial is one of the first clinical trials with a goal of designing and manufacturing actively personalized vaccines…

Continue Reading GAPVAC Project Tests An Individualized Form of  Immunotherapy to Treat Aggressive Brain Cancer
Close Menu